Asker Healthcare Group AB(SE:ASKER)
kr 71.70-1.95 (-2.65%)
SE:ASKER
Asker Healthcare Group AB financials statements
kr 71.70
At close:-1.95 (-2.65%)
Want to see SE:ASKER full AI Analyst Report?
Asker Healthcare Group AB (ASKER) Ratios
1 Followers
Asker Healthcare Group AB Ratios
SE:ASKER's free cash flow for Q3 2026 was kr249.00M. For the 2026 fiscal year, SE:ASKER's free cash flow was decreased by kr-111.00M and operating cash flow was kr360.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.36 | 1.40 | 1.40 | 1.53 | 1.76 |
| Quick Ratio | 0.85 | 0.83 | 0.89 | 0.89 | 1.09 |
| Cash Ratio | 0.22 | 0.15 | 0.14 | 0.09 | 0.29 |
| Solvency Ratio | 0.13 | 0.10 | 0.09 | 0.11 | 0.10 |
| Operating Cash Flow Ratio | 0.33 | 0.38 | 0.37 | 0.44 | 0.23 |
| Short-Term Operating Cash Flow Coverage | 2.38 | 3.28 | 4.19 | 8.49 | 2.71 |
| Net Current Asset Value | kr -4.71B | kr -5.13B | kr -4.29B | kr -4.04B | kr -2.59B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.45 | 0.44 | 0.46 | 0.53 |
| Debt-to-Equity Ratio | 0.89 | 1.72 | 1.65 | 1.72 | 2.19 |
| Debt-to-Capital Ratio | 0.47 | 0.63 | 0.62 | 0.63 | 0.69 |
| Long-Term Debt-to-Capital Ratio | 0.39 | 0.57 | 0.57 | 0.59 | 0.65 |
| Financial Leverage Ratio | 2.56 | 3.78 | 3.75 | 3.70 | 4.11 |
| Debt Service Coverage Ratio | 1.72 | 1.86 | 1.93 | 3.36 | 3.66 |
| Interest Coverage Ratio | 2.23 | 3.03 | 2.10 | 3.96 | 27.18 |
| Debt to Market Cap | 0.15 | 0.16 | 0.13 | 0.13 | 0.11 |
| Interest Debt Per Share | 17.34 | 16.38 | 13.70 | 12.84 | 10.31 |
| Net Debt to EBITDA | 2.36 | 3.72 | 4.09 | 4.06 | 5.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.07% | 39.13% | 33.59% | 32.27% | 27.93% |
| EBIT Margin | 7.60% | 5.73% | 4.25% | 6.15% | 6.47% |
| EBITDA Margin | 12.46% | 9.78% | 8.33% | 9.52% | 7.16% |
| Operating Profit Margin | 7.60% | 6.43% | 4.30% | 6.04% | 6.39% |
| Pretax Profit Margin | 3.93% | 3.72% | 2.29% | 4.79% | 5.82% |
| Net Profit Margin | 2.93% | 2.40% | 1.51% | 3.67% | 4.99% |
| Continuous Operations Profit Margin | 3.04% | 2.50% | 1.52% | 3.70% | 5.02% |
| Net Income Per EBT | 74.66% | 64.40% | 65.91% | 76.65% | 85.85% |
| EBT Per EBIT | 51.65% | 57.87% | 53.20% | 79.24% | 90.97% |
| Return on Assets (ROA) | 2.93% | 2.74% | 1.79% | 4.20% | 6.34% |
| Return on Equity (ROE) | 7.51% | 10.38% | 6.72% | 15.56% | 26.07% |
| Return on Capital Employed (ROCE) | 10.02% | 9.74% | 6.84% | 8.85% | 10.53% |
| Return on Invested Capital (ROIC) | 7.26% | 6.17% | 4.34% | 6.63% | 8.72% |
| Return on Tangible Assets | 6.67% | 5.94% | 4.03% | 9.91% | 11.76% |
| Earnings Yield | 1.58% | 1.12% | 0.63% | 1.34% | 1.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.59 | 7.63 | 6.74 | 7.10 | 8.46 |
| Payables Turnover | 6.67 | 6.81 | 6.23 | 7.58 | 7.52 |
| Inventory Turnover | 5.26 | 5.02 | 6.21 | 5.59 | 6.04 |
| Fixed Asset Turnover | 9.43 | 10.08 | 13.40 | 12.96 | 15.41 |
| Asset Turnover | 1.00 | 1.15 | 1.19 | 1.15 | 1.27 |
| Working Capital Turnover Ratio | 12.35 | 12.43 | 11.66 | 9.57 | 0.00 |
| Cash Conversion Cycle | 70.04 | 66.84 | 54.37 | 68.55 | 55.01 |
| Days of Sales Outstanding | 55.38 | 47.81 | 54.13 | 51.40 | 43.16 |
| Days of Inventory Outstanding | 69.42 | 72.66 | 58.79 | 65.31 | 60.43 |
| Days of Payables Outstanding | 54.76 | 53.63 | 58.55 | 48.15 | 48.57 |
| Operating Cycle | 124.79 | 120.47 | 112.92 | 116.71 | 103.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.61 | 3.20 | 2.75 | 2.55 | 1.00 |
| Free Cash Flow Per Share | 2.00 | 2.29 | 2.35 | 2.23 | 0.67 |
| Dividend Paid and CapEx Coverage Ratio | 2.25 | 3.53 | 6.97 | 7.93 | 3.08 |
| Capital Expenditure Coverage Ratio | 2.25 | 3.53 | 6.97 | 7.93 | 3.08 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.21 | 0.21 | 0.21 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.08 | 0.08 | 0.08 | 0.04 |
| Free Cash Flow Yield | 2.37% | 2.74% | 2.81% | 2.66% | 0.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 67.52 | 89.04 | 157.93 | 74.56 | 68.65 |
| Price-to-Sales (P/S) Ratio | 1.85 | 2.13 | 2.38 | 2.74 | 3.43 |
| Price-to-Book (P/B) Ratio | 4.74 | 9.24 | 10.61 | 11.60 | 17.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 42.11 | 36.47 | 35.58 | 37.59 | 124.26 |
| Price-to-Operating Cash Flow Ratio | 23.40 | 26.13 | 30.48 | 32.85 | 83.93 |
| Price-to-Earnings Growth (PEG) Ratio | 2.05 | 1.15 | -3.00 | -9.10 | 0.00 |
| Enterprise Value Multiple | 17.21 | 25.55 | 32.72 | 32.79 | 52.97 |
| Enterprise Value | 36.01B | 37.53B | 36.64B | 36.59B | 35.49B |
| EV to EBITDA | 17.21 | 25.55 | 32.72 | 32.79 | 52.97 |
| EV to Sales | 2.15 | 2.50 | 2.72 | 3.12 | 3.79 |
| EV to Free Cash Flow | 48.79 | 42.69 | 40.67 | 42.90 | 137.57 |
| EV to Operating Cash Flow | 27.12 | 30.58 | 34.83 | 37.49 | 92.91 |
| Tangible Book Value Per Share | -7.63 | -9.28 | -8.48 | -8.10 | -4.10 |
| Shareholders’ Equity Per Share | 17.80 | 9.06 | 7.89 | 7.21 | 4.68 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.33 | 0.33 | 0.23 | 0.14 |
| Revenue Per Share | 45.59 | 39.23 | 35.12 | 30.59 | 24.42 |
| Net Income Per Share | 1.34 | 0.94 | 0.53 | 1.12 | 1.22 |
| Tax Burden | 0.75 | 0.64 | 0.66 | 0.77 | 0.86 |
| Interest Burden | 0.52 | 0.65 | 0.54 | 0.78 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.35 | 0.32 | 0.08 | 0.06 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.32 | 1.27 | 1.82 | 1.38 | 0.82 |
Currency in SEK

